ARS Pharmaceuticals, Inc. Common Stock, Capital Shares Reserved for Future Issuance
ARS Pharmaceuticals, Inc. (SPRY) had Common Stock, Capital Shares Reserved for Future Issuance of 33.12 million shares as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-08-13
- 2026-06-30: Common Stock, Capital Shares Reserved for Future Issuance 33.12M shares.
- 2026-03-31: Common Stock, Capital Shares Reserved for Future Issuance 33.25M shares.
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 27.60M shares.
- 2025-09-30: Common Stock, Capital Shares Reserved for Future Issuance 28.05M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance | Common Stock, Capital Shares Reserved for Future Issuance as first filed |
|---|---|---|
| 2026-06-30 | 33.12M shares 10-Q · filed 2026-08-13 | |
| 2026-03-31 | 33.25M shares 10-Q · filed 2026-05-15 | |
| 2025-12-31 | 27.60M shares 10-Q · filed 2026-08-13 | |
| 2025-09-30 | 28.05M shares 10-Q · filed 2025-11-10 | |
| 2025-06-30 | 28.19M shares 10-Q · filed 2025-08-13 | |
| 2025-03-31 | 28.76M shares 10-Q · filed 2025-05-14 | |
| 2024-12-31 | 23.34M shares 10-K · filed 2026-03-09 | 21.12M shares 10-K · filed 2025-03-20 |
| 2024-09-30 | 21.90M shares 10-Q · filed 2024-11-13 | |
| 2024-06-30 | 22.10M shares 10-Q · filed 2024-08-06 | |
| 2024-03-31 | 22.43M shares 10-Q · filed 2024-05-09 | |
| 2023-12-31 | 17.76M shares 10-K · filed 2025-03-20 | |
| 2023-09-30 | 18.36M shares 10-Q · filed 2023-11-09 | |
| 2023-06-30 | 18.83M shares 10-Q · filed 2023-08-10 | |
| 2023-03-31 | 19.64M shares 10-Q · filed 2023-05-15 | |
| 2022-12-31 | 15.49M shares 10-K · filed 2024-03-21 | 15.44M shares 10-K · filed 2023-03-23 |
| 2022-09-30 | 10.35M shares 10-Q · filed 2022-11-02 | |
| 2022-06-30 | 11.06M shares 10-Q · filed 2022-08-11 | |
| 2022-03-31 | 11.09M shares 10-Q · filed 2022-05-12 | |
| 2021-12-31 | 9.33M shares 10-Q · filed 2022-11-02 | |
| 2021-09-30 | 9.38M shares 10-Q · filed 2021-11-10 | |
| 2021-06-30 | 9.43M shares 10-Q · filed 2021-08-12 | |
| 2021-03-31 | 9.56M shares 10-Q · filed 2021-05-13 | |
| 2020-12-31 | 7.93M shares 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 |